全文获取类型
收费全文 | 16448篇 |
免费 | 980篇 |
国内免费 | 648篇 |
专业分类
耳鼻咽喉 | 173篇 |
儿科学 | 574篇 |
妇产科学 | 298篇 |
基础医学 | 1225篇 |
口腔科学 | 148篇 |
临床医学 | 1496篇 |
内科学 | 4942篇 |
皮肤病学 | 190篇 |
神经病学 | 867篇 |
特种医学 | 257篇 |
外科学 | 835篇 |
综合类 | 2529篇 |
一般理论 | 2篇 |
预防医学 | 2379篇 |
眼科学 | 309篇 |
药学 | 624篇 |
4篇 | |
中国医学 | 927篇 |
肿瘤学 | 297篇 |
出版年
2024年 | 25篇 |
2023年 | 345篇 |
2022年 | 732篇 |
2021年 | 961篇 |
2020年 | 937篇 |
2019年 | 727篇 |
2018年 | 681篇 |
2017年 | 602篇 |
2016年 | 662篇 |
2015年 | 701篇 |
2014年 | 1264篇 |
2013年 | 1375篇 |
2012年 | 968篇 |
2011年 | 1121篇 |
2010年 | 932篇 |
2009年 | 795篇 |
2008年 | 725篇 |
2007年 | 639篇 |
2006年 | 496篇 |
2005年 | 448篇 |
2004年 | 367篇 |
2003年 | 404篇 |
2002年 | 283篇 |
2001年 | 246篇 |
2000年 | 168篇 |
1999年 | 142篇 |
1998年 | 110篇 |
1997年 | 130篇 |
1996年 | 91篇 |
1995年 | 73篇 |
1994年 | 76篇 |
1993年 | 47篇 |
1992年 | 43篇 |
1991年 | 45篇 |
1990年 | 35篇 |
1989年 | 24篇 |
1987年 | 33篇 |
1985年 | 52篇 |
1984年 | 62篇 |
1983年 | 39篇 |
1982年 | 38篇 |
1981年 | 44篇 |
1980年 | 60篇 |
1979年 | 48篇 |
1978年 | 31篇 |
1976年 | 28篇 |
1974年 | 23篇 |
1973年 | 33篇 |
1972年 | 25篇 |
1971年 | 25篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
22.
23.
24.
《Clinical Lymphoma, Myeloma & Leukemia》2020,20(8):e461-e467
IntroductionVon Willebrand factor (vWF) cleaving protease ADAMTS-13 has a key role for maintaining normal size of vWF. A deficiency or dysfunction of vWF cleaving protease is associated with ultra large vWF multimers and thrombotic microangiopathy. Patients with cancers have reduced levels of vWF cleaving protease. In this pilot study, we have evaluated whether or not deficiencies of ADAMTS-13 were present in myelodysplastic syndromes (MDS). Moreover, we assessed if a reduction in basal levels of ADAMTS-13 may play a role in the prognosis of MDS.Patients and MethodsWe measured and compared the levels of vWF cleaving protease ADAMTS-13 in 100 patients with MDS and 35 healthy controls. Patients were divided into 2 groups according to the International Prognostic Scoring System: group I consisting of 44 patients with low-risk MDS and group II of 56 patients with high-risk MDS. Patients with high-risk and low-risk MDS presented significantly lower levels of ADAMTS-13 than controls (P < .001 and P = .0177, respectively). High-risk patients had significantly lower levels of ADAMTS-13 when compared with the low-risk group (P < .001).ResultsWe found that reduced levels of ADAMTS-13 have a relationship with overall survival (P < .001). Statistical analysis showed that ADAMTS-13 correlates with cytogenetics (P < .001) and a tendency of slight correlation with platelet count and basal levels of ADAMTS-13 (R, 0.35; P value, 0.001). Moreover, we found that levels of ADAMTS-13 have correlation with response to treatment (P < .001).ConclusionsADAMTS-13 in MDS might represent a surrogate marker of prognosis, response to therapy, or disease progression. Further studies are needed. 相似文献
25.
26.
目的 探讨中性粒细胞与淋巴细胞比值(neutrophil to lymphocyte ratio,NLR)对三阴性乳腺癌的临床预后影响及与Ki - 67表达的关系。方法 回顾性分析2006年1月 - 2012年12月于我院乳腺外科住院治疗的134例三阴性乳腺癌患者。NLR最佳临床分界值采用ROC曲线确定,并依此分NLR<2.64组和NLR≥2.64组。临床独立预后因素采用单因素和多因素Cox回归模型分析。术后生存时间和生存曲线比较采用Kaplan - Meier和log - rank方法。Ki - 67的表达采用免疫组织化学方法检测。结果 NLR是三阴性乳腺癌的独立预后因素,最佳临界值为2.64。NLR<2.64组术后中位DFS为39.10月,中位OS为52.30月;NLR≥2.64组术后中位DFS为27.35月,中位OS为37.35月。2组术后DFS和OS比较,差异具有统计学意义(P<0.05)。NLR低组伴Ki - 67表达阴性的三阴性患者术后中位DFS和OS生存时间显著高于其他情况。结论 NLR是三阴性乳腺癌的关键影响预后因素,具有重复性强、非侵袭性、方便实用等特性,可用于预测三阴性乳腺癌临床预后。 相似文献
27.
28.
29.
30.
Benjamin R. Griffin J. Pedro Teixeira Sophia Ambruso Michael Bronsert Jay D. Pal Joseph C. Cleveland T. Brett Reece David A. Fullerton Sarah Faubel Muhammad Aftab 《The Journal of thoracic and cardiovascular surgery》2021,161(4):1346-1355.e3
ObjectivesSevere acute kidney injury (AKI) is a known risk factor for infection and mortality. However, whether stage 1 AKI is a risk factor for infection has not been evaluated in adults. We hypothesized that stage 1 AKI following cardiac surgery would independently associate with infection and mortality.MethodsIn this retrospective propensity score–matched study, we evaluated 1620 adult patients who underwent nonemergent cardiac surgery at the University of Colorado Hospital from 2011 to 2017. Patients who developed stage 1 AKI by Kidney Disease Improving Global Outcomes creatinine criteria within 72 hours of surgery were matched to patients who did not develop AKI. The primary outcome was an infection, defined as a new surgical-site infection, positive blood or urine culture, or development of pneumonia. Secondary outcomes included in-hospital mortality, stroke, and intensive care unit (ICU) and hospital length of stay (LOS).ResultsStage 1 AKI occurred in 293 patients (18.3%). Infection occurred in 20.9% of patients with stage 1 AKI compared with 8.1% in the no-AKI group (P < .001). In propensity-score matched analysis, stage 1 AKI independently associated with increased infection (odds ratio [OR]; 2.24, 95% confidence interval [CI], 1.37-3.17), ICU LOS (OR, 2.38; 95% CI, 1.71–3.31), and hospital LOS (OR, 1.30; 95% CI, 1.17-1.45).ConclusionsStage 1 AKI is independently associated with postoperative infection, ICU LOS, and hospital LOS. Treatment strategies focused on prevention, early recognition, and optimal medical management of AKI may decrease significant postoperative morbidity. 相似文献